Pharmaron

#SOT2026 Day 1 is buzzing! Visit Pharmaron at booth 2134 to explore our safety and toxicology expertise for end-to-end drug development. Missed the morning poster? Grab it online. 4 more posters this afternoon - come find us! #SOT2026 #safetyassessment #toxicology #safety

Pharmaron is headed to Dallas, Texas for this year's WRIB conference! Make sure to meet our experts at Booth #41 to learn how our innovative bioanalytical capabilities can enhance your projects. See you in Texas! #Pharmaron #WRIB #Bioanalysis #Texas

We are in San Diego for SOT 2026 and excited to see everyone! Come by our booth 2134, and connect with us to discuss your questions around safety and toxicology from end-to-end on your molecules and processes! #SOT2026 #toxicology #safety #end-to-end-drug-development

Explore how Pharmaron’s 65,000 sq. ft. facility supports large-animal GLP studies for high-risk devices. pharmaron.life/3YmO4MU #Pharmaron #PreclinicalResearch #MedicalDevices

Pharmaron is excited for 42nd SCI Symposium 2026 at Churchill's College, Cambridge at Booth 5 from 15-17 April. Our team Natalie Windle, Innocent Mushi, and Sidonie Aubert will be there to connect with you. Schedule a meeting: pharmaron.life/47Cv6q2

From Discovery to NDA: Pharmaron’s DMPK strategy is built for every phase. Whether you're optimizing lead compounds or preparing for regulatory submission, our integrated DMPK services ensure milestone-ready data and reduced development risk. pharmaron.life/3WHv4aC #DMPK

At Pharmaron, we specialize in 𝐩𝐫𝐞𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐬𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐟𝐨𝐫 𝐨𝐜𝐮𝐥𝐚𝐫 𝐜𝐞𝐥𝐥 𝐚𝐧𝐝 𝐠𝐞𝐧𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 (𝐂𝐆𝐓) products—helping innovators move confidently toward First-in-Human (FIH) trials.  Learn more: pharmaron.life/3YlKUZc

Pharmaron is proud to share our latest research next week in San Diego at SOT 2026!   Don’t miss a chance to connect with our team at SOT 2026.

Explore how different mouse tumor models respond to various X-ray irradiation regimens. Check out our poster detailing the responses of 17 mouse tumor models to a range of irradiation treatments. #cancerresearch

Not all testing is equal. Learn how to align in vivo studies with FDA and EMA expectations. pharmaron.life/42XnStK #Pharmaron #MedicalDeviceR&D #InVivoScience

Pharmaron is excited to attend the 42nd SCI Symposium at Churchill College, Cambridge from 15th – 17th April. Come see us at Booth 5 to discuss our API Process Development and Manufacturing Services. See you in Cambridge! #SCI. Book a meeting: pharmaron.life/4hJjdAM

Discover cutting-edge tools for targeted protein degradation with Pharmaron’s custom cell lines and assays. Explore our 8+ years of experience in protein degrader discovery! #TPD #PROTAC #DrugDiscovery #Proteindegraders

At Pharmaron, we understand the complexity of developing ocular medical devices—and we’re here to help you navigate it with confidence.   Learn more: pharmaron.life/4rUUvUG

Experience precision like never before. Pharmaron’s fully automated Explorer G3 suite delivers reproducibility for biochemical & cell-based assays—up to 200 plates/day. #DrugDiscovery #HTS #Automation #Pharmaron #Biotech

March 8. International Women's Day. Name one woman in science who shaped how you work. Drop her name below. At Pharmaron, we are proud of the women who keep the science moving. #InternationalWomensDay #WomenInScience

Refine design, reduce costs, and train physicians—all through BioSkills cadaver studies. pharmaron.life/4jwTM7d #Pharmaron #MedicalDevices #PreclinicalTesting

Pharmaron’s analysis reveals donor- and assay-dependent variability in calculated “d” values, especially at the mRNA level. #CYPInduction #DDI #PharmaronDMPK Download: pharmaron.life/49D483m

At Pharmaron, we provide 𝐆𝐋𝐏-𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐭 𝐨𝐜𝐮𝐥𝐚𝐫 𝐭𝐨𝐱𝐢𝐜𝐨𝐥𝐨𝐠𝐲 𝐬𝐞𝐫𝐯𝐢𝐜𝐞𝐬 designed to support the safety evaluation of ophthalmic products—from small molecules and biologics to gene therapies and ocular devices.  Learn more: pharmaron.life/3Msspjb

From single assays to full programs, Pharmaron supports kinase discovery with agility and precision. #drugdiscovery #Pharmaron #kinase

Rare Disease Day. Small populations make every data point count. Share protocols, align endpoints, publish negatives. What would make rare disease studies easier to run well? #RareDiseaseDay #ClinicalResearch